Lymph node histology in head and neck cancer: Impact of immunotherapy with IRX-2

International Immunopharmacology

Volumn 3, Issue 8, 2003, Pages 1083-1091

  Meneses, Abelardo ^a   Verastegui, Emma ^a   Barrera, Jose L ^a   De la Garza, Jaime ^a   Hadden, John W ^b,c  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Instituto Nacional de Cancerologia ^*  (United States)

Author keywords

Immunotherapy; IRX 2; Lymph nodes

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDOMETACIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; IRX 1; IRX 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC;

ADVANCED CANCER; B LYMPHOCYTE; CANCER IMMUNOTHERAPY; CANCER PATIENT; CELL DENSITY; CELL INFILTRATION; CELL SIZE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GIANT CELL; GRANULOCYTE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; LYMPH NODE; LYMPH NODE BIOPSY; LYMPHOID CELL; MACROPHAGE; MEDICAL ASSESSMENT; MORPHOLOGY; OUTCOMES RESEARCH; PLASMA CELL; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SAMPLE; SINUS HISTIOCYTOSIS; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; TUMOR REGRESSION; VITAMIN INTAKE;

EID: 0037632262     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00017-1     Document Type: Conference Paper

References (28)

1. Barrera J., Verastegui E., Meneses A., de la Garza J., Zinser J., Hadden J.W. Neoadjuvant immunological treatment with IRX-2 in patients with advanced oral cavity squamous cell carcinoma of the head and neck induces clinical and histological responses. Alverez Vicent J.J. 1st World Congress on Head and Neck Oncology. 1998;1017-1019 Monduzzi, Bologna, Italy.
2. Barrera J., Verastegui E., Meneses A., Zinser J., de la Garza J., Hadden J.W. Combination immunotherapy of squamous cell head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 126:2000;45-55.
3. Berlinger N., Tsakraklides V., Pollak K., Adams C., Yang M., Good R.A. Prognostic significance of lymph node histology in patients with squamous cell carcinoma of the larynx, pharynx, and oral cavity. Laryngoscope. 86:1975;792-803.
4. Cernea C., Montenegro F., Castro I., Cordeire A., Gayette L., Ferraz A.et al. Prognostic significance of lymph node reactivity in the control of pathologic negative node squamous cell carcinoma of the oral cavity. Am. J. Surg. 174:1997;531-542.
5. Chung C.K., Stryker J.A., Abt A.B., Cunningham D.E., Strauss M., Connor G.H. Histologic grading in the clinical evaluation of laryngeal carcinoma. Arch. Otolaryngol. 106:1980;623-628.
6. Hadden J.W., Endicott J., Baekey P., Skipper P., Hadden E.M. Interleukins and contrasuppression induce immune regression of head and neck cancer. Int. Arch. Otolaryngol. Head Neck Surg. 120:1994;395-403.
7. Hadden J.W. Immunology and pharmacology of head and neck cancer: an update. Int. J. Immunopharmacol. 11:1997;629-644.
8. Hadden J.W. Immunology of head and neck cancer: prospects for immunotherapy. Clin. Immunother. 3:1995;362-374.
9. Klein E., Svedmyr E., Jondal M.et al. Functional studies on tumor-infiltrating lymphocytes in man. Isr. J. Med. Sci. 12(7):1977;747-752.
10. Koneval T., Applebaum E., Popovic D. Demonstration of immunoglobulin in tumor and marginal tissues of squamous cell carcinomas of the head and neck. J. Natl. Cancer Inst. 59:1977;1089-1094.
11. Maass G., Schmidt W., Berger M. Priming of tumor-specific T cells in the draining nodes after immunization with IL-2 secreting tumor cells. Proc. Natl. Acad. Sci. U. S. A. 92:1995;SS40-SS42.
12. Mandell-Brown M., Johnson J.T., Robin B., Howell E., Wagner I. Neck node immunotherapy in head and neck cancer. Otolaryngology. 95:1986;500-506.
13. Meneses A., Verastegui E., Barrera J., Zinser J., de la Garza J., Hadden J.W. Histological findings in patients with head and neck squamous cell carcinoma receiving perilymphatic natural cytokine mixture prior to surgery. Arch. Pathol. Lab. Med. 122:1998;447-454.
14. Mukhopadhyaya R., Tatake R., Rishnan N., Rao R., Fakih A., Naik S.et al. Immunoreactivity from lymphocytes from draining lymph nodes and peripheral blood and tumor infiltrates from oral cancer patients. J. Clin. Lab. Immunol. 30:1989;21-25.
15. Paavolainen M., Tarkkenen J., Saksela E. Stroma reactions as prognostic factors in epidermal carcinoma of the tongue. Acta Otolaryngol. 75:1977;316-321.
16. Patt B., Chose L., Vuitch F. Prognostic significance of sinus histiocytosis in metastatic laryngeal cancer. Laryngoscope. 103:1993;498-502.
17. Polhris E., Eichhorn T., Glanz H., Kleinasser O. Immunohistological reactions of cervical lymph nodes in patients with laryngeal carcinomas. Arch. Otorhinolaryngol. 244:1987;278-283.
18. Riegrova O., Jansa P. Regional lymph nodes in cancer I-II. Acta Univ. Palacki. Olomuc. 126:1990;45-55.
19. Riegrova O., Jansa P. Regional lymph nodes in cancer III-IV. Acta Univ. Palacki. Olomuc. 130:1991;131-142.
20. Ring A., Sako K., Rao V., Razak M., Rrese P. Immunologic antigens of regional lymph nodes in squamous cell carcinoma of the floor of the mouth. Ann. J. Surg. 150:1985;461-465.
21. Schuller A. Assessment of neck node reactivity in head and neck cancer. Laryngoscope. 94:1984;1-55.
22. Snyderman C., Heo P., Johnson T., D'Amico F., Barnes L., White K. Functional and phenotype analysis of lymphocytes in head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 118:1991;899-905.
23. Verastegui E., Barrera J., Zinser J.et al. A natural cytokine mixture (IRX-2) and interference with immune suppression induce immune mobilization and regression of head and neck cancer. Int. J. Immunopharmacol. 19:1997;619-627.
24. Verastegui E., Hadden E.M., Barrera J., Meneses A., Hadden J.W. A natural cytokine mixture (IRX-2) and interference with immune suppression induce immune regression and improved survival in head and neck cancer. Int. J. Immunorehabil. 12:1999;5-11. [Suppl.].
25. Verastegui E., Morales R., Barrera J.L., Mueller A., Hadden J.et al. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck. Clin. Immunol. 102:2002;37-47.
26. Vitolo D., Letessier E., Johnson T., Whiteside T.L. Immunologic effector cells in head and cancer. JNCI Monogr. 13:1992;203-208.
27. Wang M.P., Lichtenstein A., Michel R. Hierarchical immunosuppression of regional lymph nodes in patients with head and neck squamous cell cancer. Arch. Otolaryngol. Head Neck Surg. 105:1991;517-527.
28. Wolff G., Hudson J., Peterson K., Miller H., Mc Clatchey K. Lymphocyte subpopulation infiltrating squamous cell cancers of the head and neck generations with content of tumor and progression. Arch. Otolaryngol. Head Neck Surg. 45:1986;142-152.